MedVellum
MedVellum
Back to Library
Endocrinology
Endocrine Surgery
General Practice
Nephrology

Primary Hyperparathyroidism

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Severe hypercalcaemia (greater than 3.0 mmol/L or symptomatic)
  • Evidence of renal failure
  • Pancreatitis
  • Severe osteoporosis or fragility fracture
  • Hypercalcaemic crisis (confusion, dehydration)
Overview

Primary Hyperparathyroidism

1. Clinical Overview

Summary

Primary Hyperparathyroidism (PHPT) is a disorder of inappropriate parathyroid hormone (PTH) hypersecretion, resulting in hypercalcaemia and hypophosphataemia. It is the most common cause of hypercalcaemia in the outpatient setting. The condition is usually caused by a solitary parathyroid adenoma (80-85%). While the classic presentation involves "bones, stones, abdominal groans, and psychic moans," most modern patients are asymptomatic ("biochemical PHPT") diagnosed incidentally. Definitive management is surgical parathyroidectomy, indicated for all symptomatic patients and asymptomatic patients meeting specific criteria (age less than 50, renal/bone involvement). [1,2]

Key Facts

  • Incidence: 1-7 per 1,000 adults; peak incidence in post-menopausal women (50-60 years).
  • Cause: Solitary adenoma (85%), Multi-gland hyperplasia (15%), Carcinoma (less than 1%).
  • Biochemistry: Hypercalcaemia + Elevated (or inappropriately normal) PTH + Low Phosphate.
  • Diagnosis exclusion: Familial Hypocalciuric Hypercalcaemia (FHH) must be excluded before surgery.
  • Treatment: Surgery is the unique curative therapy (cure rate >95%).
  • Surgical Localisation: Sestamibi scan (nuclear medicine) and Ultrasound are standard.

Clinical Pearls

Inappropriately Normal PTH: A patient with hypercalcaemia should have a SUPPRESSED PTH (e.g., less than 1.0 pmol/L). If calcium is high (2.8 mmol/L) and PTH is "normal" (e.g., 4.5 pmol/L, within range 1.6-6.9), this is Primary Hyperparathyroidism. The PTH is inappropriate for the calcium level.

Exclude FHH: Before referring for surgery, check the 24-hour urinary calcium. Familial Hypocalciuric Hypercalcaemia (FHH) mimics PHPT but is benign effectively and surgery does not help. Low urine calcium (Ca/Cr clearance less than 0.01) suggests FHH.

Hungry Bone Syndrome: After removing a parathyroid adenoma in a patient with severe bone disease, the "starved" bones rapidly uptake calcium, causing severe, prolonged Post-Op Hypocalcaemia. Watch for tingling and tetany.

Normocalcaemic PHPT: A variant where calcium is normal but PTH is consistently high (after excluding vitamin D deficiency and CKD). These patients may progress to classic PHPT.


2. Epidemiology

Incidence and Demographics

  • Prevalence: 0.3% of general population; up to 2-3% in post-menopausal women.
  • Sex Ratio: Female:Male = 3-4:1.
  • Age: Peak 5th and 6th decades.

Aetiology

  1. Sporadic (90-95%):
    • Solitary Adenoma (80-85%).
    • Double Adenoma (2-5%).
    • Four-gland Hyperplasia (10-15%).
    • Parathyroid Carcinoma (less than 1%).
  2. Familial / Genetic (5-10%):
    • MEN1: Multiple Endocrine Neoplasia Type 1 (3 Ps: Parathyroid, Pituitary, Pancreas). Usually multigland hyperplasia.
    • MEN2A: Medullary Thyroid Cancer, Phaeochromocytoma, Hyperparathyroidism.
    • Hyperparathyroidism-Jaw Tumour Syndrome: High risk of carcinoma.
    • Familial Isolated Hyperparathyroidism.

3. Pathophysiology

Physiological Regulation (Normal)

  • Parathyroid glands sense Calcium via Calcium-Sensing Receptor (CaSR).
  • High Calcium → Inhibits PTH secretion.
  • Low Calcium → Stimulates PTH secretion.

Disorder Mechanism

  • Set-point Error: The neoplastic parathyroid tissue has a higher "set-point" for calcium suppression or reduced expression of CaSR.
  • Autonomous Secretion: PTH is secreted despite high calcium.

Effects of Excess PTH

  1. Kidney:
    • Increases Calcium reabsorption (distal tubule).
    • Increases Phosphate excretion (proximal tubule) → Hypophosphataemia.
    • Activates 1-alpha-hydroxylase → Increases 1,25(OH)2-Vitamin D.
  2. Bone:
    • Stimulates osteoclasts → Bone resorption.
    • Releases Calcium and Phosphate into blood.
    • Chronic: Cortical bone loss (distal radius), Osteitis Fibrosa Cystica ("Brown Tumours").
  3. Gut:
    • Increased Calcium absorption (mediated by high Vitamin D).

4. Clinical Presentation

"Biochemical" PHPT (Asymptomatic - 80%)

Symptomatic PHPT (Classics)

Mnemonic: "Bones, Stones, Abdominal Groans, and Psychic Moans"

SystemClinical Features
Renal ("Stones")Nephrolithiasis (calcium oxalate/phosphate), Nephrocalcinosis, Polyuria/Polydipsia, Renal failure.
Skeletal ("Bones")Osteoporosis (predilection for cortical bone - forearm/hip). Fragility fractures. Osteitis Fibrosa Cystica (rare today: bone pain, subperiosteal resorption on X-ray).
GI ("Groans")Constipation, Nausea, Peptic Ulcer Disease (gastrin stimulation), Pancreatitis (calcium activates enzymes).
Neuro ("Moans")Depression, Anxiety, Cognitive decline ("brain fog"), Lethargy, Coma (severe crisis).
CardiovascularHypertension, Short QT interval, Left Ventricular Hypertrophy.
NeuromuscularProximal muscle weakness (e.g., unable to rise from chair).

Red Flags for Parathyroid Carcinoma


Detected on routine screening panels.
Common presentation.
Mild hypercalcaemia.
Common presentation.
Patient feels well, or identifies mild symptoms (fatigue, brain fog) only retrospectively after cure.
Common presentation.
5. Clinical Examination

General

  • Dehydration signs.
  • Confusion (if severe).

Neck

  • Inspection: Thyrotoxicosis scar?
  • Palpation: Usually NORMAL. A typical adenoma (1-2cm, 1g) is too soft/deep to feel.
    • If you feel a mass: Thyroid nodule? Parathyroid Carcinoma?
  • Vocal Cords: Check voice (hoarseness).

Skeletal

  • Vertebral tenderness (fractures).
  • Proximal myopathy testing.

6. Investigations

Biochemistry

Diagnostic Profile:

  1. Calcium: Elevated (Adjusted for albumin).
  2. PTH: Elevated (>6.9 pmol/L) OR Inappropriately Normal (e.g. 4.0-6.9 in presence of hypercalcaemia).
  3. Phosphate: Low or Low-Normal (Phosphaturic effect of PTH).
  4. Vitamin D (25-OH): Often low (PTH converts it to 1,25). IMPORTANT: Replete Vit D before confirming diagnosis, as low Vit D stimulates PTH (secondary effect).
  5. Creatinine: Check renal function.

Exclusion of Mimics

  • 24-hour Urine Calcium:
    • PHPT: Normal or High (>5 mmol/24h).
    • FHH: Low (less than 5 mmol/24h). Calcium/Creatinine Clearance Ratio (CCCR) less than 0.01 indicates FHH.

Localisation Studies (Pre-Op)

Only required if surgery is planned. Not for diagnosis.

  1. Sestamibi Scan (99mTc-sestamibi):
    • Nuclear scan.
    • Parathyroids retain tracer longer than thyroid.
    • Sensitivity: 80-90% for adenoma.
  2. Neck Ultrasound:
    • Identifies enlarged gland (hypoechoic, vascular).
    • Checks for concomitant thyroid nodules.
  3. 4D-CT ("Parathyroid CT"):
    • Evaluation of "fourth dimension" (perfusion wash-in/wash-out).
    • Used if MIBI/USS negative.

Bone Assessment

  • DEXA Scan: Check Lumbar Spine, Hip, and Distal Radius (One-third radius site is most sensitive for PTH-mediated cortical bone loss).
  • Abdominal X-ray/US/CT: Check for renal stones.

7. Management

Management Algorithm

           DIAGNOSIS CONFIRMED
           (High Ca, High/Norm PTH)
                        ↓
            EXCLUDE FHH (Urine Ca)
                        ↓
┌─────────────────────────────────────────────┐
│             ARE THERE SYMPTOMS?             │
│  (Stones, Fractures, Ca >3.0, Symptoms)     │
└─────────────────────────────────────────────┘
          ↙ YES                   NO ↘
    INDICATED FOR           MEETS GUIDELINES? (Bilezikian)
    SURGERY                 - Age less than 50
                            - Ca >0.25 above limit
                            - GFR less than 60
                            - T-score less than -2.5 or Fracture
                            - Stones present
          ↙ YES                   NO ↘
    SURGICAL CONSULT        MEDICAL MONITORING
    (Localese & Excise)     (Annual Ca/Cr, DEXA 2yr)

Surgical Management (Parathyroidectomy)

Curative Treatment.

  1. Focused Parathyroidectomy (MIP):
    • If Localisation (MIBI + USS) concordant on single gland.
    • Small incision (~2cm).
    • High success, low complication.
  2. Bilateral Neck Exploration:
    • If localisation negative or discordant.
    • Inspect all 4 glands. Remove enlarged ones.
  3. Intra-operative PTH Monitoring:
    • PTH has short half-life (3-5 mins).
    • Measure PTH after adenoma removal.
    • Drop of >50% confirms cure (Miami Criteria).

Medical Management

For patients unfit for surgery or who decline.

  1. Observation:
    • Annual Serum Calcium, Creatinine.
    • DEXA every 1-2 years.
  2. Pharmacotherapy:
    • Cinacalcet: Calcimimetic. Increases sensitivity of CaSR to calcium. Lowers PTH and Serum Calcium. Does NOT improve bone density.
    • Bisphosphonates (Alendronate): Improve bone density. Minimal effect on serum calcium.
    • Avoid Thiazides: They increase calcium.
    • Hydration: Maintain good fluid intake.

8. Complications

Disease Complications

  • Kidney Stones (Recurrent).
  • Renal Failure (Nephrocalcinosis).
  • Osteoporotic Fractures.
  • Cardiac Arrhythmias (Short QT).
  • Pancreatitis.
  • Hypercalcaemic Crisis (Parathyroid storm).

Surgical Complications

  • Recurrent Laryngeal Nerve Injury (less than 1%): Hoarseness.
  • Hypocalcaemia (Transient): Common, treated with oral calcium/Vit D.
  • Hungry Bone Syndrome: Severe, prolonged hypocalcaemia as bones remineralise. Requires aggressive IV calcium/Active Vit D.
  • Permanent Hypoparathyroidism: If all glands damaged/removed.
  • Persistence/Recurrence: 2-5%.

9. Prognosis and Outcomes

Cure Rates

  • Surgery: >95-98% permanent cure.
  • Recurrence: Rare in sporadic adenoma. Higher in MEN1 or Carcinoma.

Long-term Benefits

  • Bone density improves significantly (10-15% increase in first year).
  • Fracture risk returns to normal.
  • Stone formation risk drops.
  • Neurocognitive symptoms may improve (variable).
  • Cardiovascular mortality risk reduces.

10. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
Asymptomatic PHPTFourth International Workshop (Bilezikian)Defines surgical criteria for asymptomatic patients.
Medical ManagementEndocrine SocietyCinacalcet for Ca control; Bisphosphonates for BMD.
NICE NG132UKOffer surgery to all with symptoms or meeting Workshop criteria.

Landmark Studies

1. Silverberg et al (1999) - Natural History

  • Question: Surgery vs Observation in asymptomatic PHPT?
  • Result: Surgery improved bone density. Observation group stable for years but some progressed.
  • Impact: Justified observation in correctly selected patients.

2. Fourth International Workshop (2014) Criteria for Surgery Surgery recommended if ANY met:

  1. Serum Ca >0.25 mmol/L (>1mg/dL) above upper limit.
  2. Skeletal: T-score less than -2.5 (Lumbar, Hip, or Radius) or Vertebral Fracture.
  3. Renal: eGFR less than 60 ml/min.
  4. Renal: Stones or Nephrocalcinosis on imaging, or High Urine Ca risk.
  5. Age less than 50 years.

11. Patient and Layperson Explanation

What is Primary Hyperparathyroidism?

You have four tiny glands in your neck (behind the thyroid) called parathyroid glands. Their job is to control calcium levels. In this condition, one of these glands has grown a benign lump (adenoma) and is working overtime, putting too much hormone into your blood.

What does the hormone do?

It takes calcium OUT of your bones and puts it into your blood. This causes two problems:

  1. High Blood Calcium: Can make you feel tired, thirsty, confused, or cause kidney stones.
  2. Weak Bones: Because the calcium is being stripped out, your bones become thinner (osteoporosis).

Why do I have it?

It is usually just "bad luck" - a single cell grew into a benign lump. It is rarely cancerous (less than 1%). It is more common in women after menopause.

How is it treated?

  • Surgery: This is the only cure. A surgeon removes the one overactive gland (or glands) through a small cut in the neck. It takes about 45 minutes and has a very high success rate.
  • Monitoring: If your calcium is only slightly high and your bones/kidneys are healthy, we might just watch it with yearly blood tests and bone scans.

12. References

Primary Sources

  1. Bilezikian JP, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3561-3569. PMID: 25078146.
  2. NICE Guideline NG132. Hyperparathyroidism (primary): diagnosis, assessment and initial management. 2019.
  3. Minisola S, et al. Primary Hyperparathyroidism. Nat Rev Dis Primers. 2018;4:18037.
  4. Wilhelm SM, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151:959-968.

13. Examination Focus

Common Exam Questions

  1. MRCP/USMLE: "A 55-year-old woman has Calcium 2.85, Phos 0.6, PTH 6.5 (Normal 1.6-6.9). Diagnosis?"
    • Answer: Primary Hyperparathyroidism. (PTH is inappropriately normal for the high calcium).
  2. Surgical: "What are the indications for surgery in asymptomatic PHPT?"
    • Answer: Age less than 50, Ca >0.25 above limit, Osteoporosis (less than -2.5), Renal impairment (less than 60), Stones.
  3. Pathology: "Distinguish PHPT from FHH."
    • Answer: Urine Calcium. Low in FHH, Normal/High in PHPT.
  4. Radiology: "What is the classic X-ray finding in severe disease?"
    • Answer: Subperiosteal resorption (radial aspect of middle phalanges) or Pepper-pot skull.

Viva Points

  • Sestamibi: Sestamibi concentrates in mitochondria-rich tissue (adenoma/heart). Washout is slower in parathyroid than thyroid.
  • Intraop PTH: Miami criteria: >50% drop from baseline 10 mins after excision = Cure.
  • MEN Syndromes: Always consider MEN1 (3Ps) in young patients (less than 30).

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24

Red Flags

  • Severe hypercalcaemia (greater than 3.0 mmol/L or symptomatic)
  • Evidence of renal failure
  • Pancreatitis
  • Severe osteoporosis or fragility fracture
  • Hypercalcaemic crisis (confusion, dehydration)

Clinical Pearls

  • **Normocalcaemic PHPT**: A variant where calcium is normal but PTH is consistently high (after excluding vitamin D deficiency and CKD). These patients may progress to classic PHPT.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines